Valuation: DarioHealth Corp.

Market Cap 23.42M 21M 19.36M 17.58M 33.27M 2.2B 34.2M 232M 92.34M 1.18B 87.9M 86.03M 3.72B P/E 2026 *
-0.6x
P/E 2027 * -1.06x
Enterprise Value 34.77M 31.18M 28.74M 26.1M 49.39M 3.26B 50.77M 344M 137M 1.75B 130M 128M 5.52B EV / Sales 2026 *
1.6x
EV / Sales 2027 * 1.64x
Free-Float
78.35%
Yield 2026 *
-
Yield 2027 * -
1 day+16.02%
1 week-20.33%
Current month-20.33%
1 month-58.79%
3 months-68.80%
6 months-69.40%
Current year-79.00%
1 week 1.7
Extreme 1.6953
2.95
1 month 1.7
Extreme 1.6953
6.36
Current year 1.7
Extreme 1.6953
13.64
1 year 1.7
Extreme 1.6953
14.77
3 years 1.7
Extreme 1.6953
52
5 years 1.7
Extreme 1.6953
357.8
10 years 1.7
Extreme 1.6953
1,880
Manager TitleAgeSince
Corporate Officer/Principal - 11/08/2011
Chief Executive Officer 52 09/08/2013
Director of Finance/CFO 38 01/01/2021
Director TitleAgeSince
Chairman 52 23/11/2014
Director/Board Member 68 12/11/2013
Director/Board Member 57 23/11/2014
Date Insider Type Main position Quantity % Market Cap. Importance
24/9/26 Free

Chairman

54,000 0.5510%
24/9/26 Free

Director

61,000 0.6225%
24/9/26 Free

Director

28,000 0.2857%
Change 5-day change 1-year change 3-year change Capi.($)
+16.02%-20.33%-81.63%-88.83% 23.42M
-0.05%+0.97%-12.26%+17.55% 191B
-1.17%+2.74%+9.64%+43.73% 124B
-0.44%+4.42%-8.66%+18.52% 123B
-1.25%-2.19%-41.36%+4.63% 96.14B
+0.85%+2.41%-4.37%+76.50% 66.54B
-1.23%+7.29%+17.05%-9.39% 57.91B
-1.42%+3.66%-1.82%+62.49% 54.89B
+1.47%-2.27%-4.29%+54.83% 49.1B
-8.69%+3.41%+4.00%-4.71% 36.19B
Average +0.39%+0.12%-12.37%+17.53% 80B
Weighted average by Cap. -0.85%+2.37%-7.08%+27.53%

Financials

2026 *2027 *
Net sales 21.75M 19.5M 17.97M 16.32M 30.89M 2.04B 31.76M 215M 85.74M 1.09B 81.62M 79.88M 3.45B 29.49M 26.45M 24.37M 22.13M 41.89M 2.76B 43.06M 292M 116M 1.48B 111M 108M 4.68B
Net income -32.48M -29.13M -26.85M -24.38M -46.14M -3.05B -47.43M -321M -128M -1.63B -122M -119M -5.16B -22.08M -19.8M -18.25M -16.57M -31.37M -2.07B -32.24M -219M -87.06M -1.11B -82.87M -81.11M -3.51B
Net Debt 11.35M 10.18M 9.38M 8.52M 16.12M 1.06B 16.57M 112M 44.74M 570M 42.58M 41.68M 1.8B 25.07M 22.49M 20.72M 18.82M 35.62M 2.35B 36.61M 248M 98.86M 1.26B 94.1M 92.1M 3.98B
Projected Income Statement - Annual - DarioHealth Corp.
Logo DarioHealth Corp.
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Employees
163
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - DarioHealth Corp.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.390USD
Average target price
10.33USD
Spread / Average Target
+332.36%
  1. Stock Market
  2. Stocks
  3. DRIO Stock